Abstract

Human papillomavirus (HPV) vaccines were licensed based on their efficacy at reducing incidence of high-grade intraepithelial neoplasia, a precursor to

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call